 Amneet Sandhu
Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 14 | 2025 | 376 | 6.440 |
Why?
| | Catheter Ablation | 13 | 2025 | 336 | 4.310 |
Why?
| | Atrial Appendage | 3 | 2024 | 15 | 2.470 |
Why?
| | Transcatheter Aortic Valve Replacement | 5 | 2023 | 121 | 2.190 |
Why?
| | Pacemaker, Artificial | 5 | 2023 | 110 | 1.930 |
Why?
| | Aortic Valve Stenosis | 5 | 2023 | 218 | 1.670 |
Why?
| | Defibrillators, Implantable | 7 | 2021 | 300 | 1.530 |
Why?
| | Stroke | 4 | 2024 | 1071 | 1.510 |
Why?
| | Cardiac Resynchronization Therapy | 3 | 2021 | 45 | 1.390 |
Why?
| | Percutaneous Coronary Intervention | 5 | 2017 | 467 | 1.370 |
Why?
| | Ventricular Premature Complexes | 5 | 2025 | 36 | 1.360 |
Why?
| | Arrhythmias, Cardiac | 4 | 2021 | 320 | 1.350 |
Why?
| | Tachycardia, Ventricular | 7 | 2022 | 168 | 1.180 |
Why?
| | Ventricular Dysfunction, Left | 4 | 2025 | 385 | 1.170 |
Why?
| | Coronary Stenosis | 2 | 2017 | 39 | 1.010 |
Why?
| | Hospitals | 4 | 2019 | 637 | 0.960 |
Why?
| | Tachycardia, Atrioventricular Nodal Reentry | 2 | 2021 | 30 | 0.870 |
Why?
| | Heart Atria | 3 | 2024 | 129 | 0.830 |
Why?
| | Aortic Valve | 5 | 2023 | 347 | 0.820 |
Why?
| | Pericardial Effusion | 1 | 2022 | 21 | 0.810 |
Why?
| | Anticoagulants | 5 | 2024 | 637 | 0.760 |
Why?
| | Risk Factors | 17 | 2025 | 9786 | 0.740 |
Why?
| | Electrophysiologic Techniques, Cardiac | 2 | 2019 | 79 | 0.720 |
Why?
| | Esophagus | 2 | 2023 | 248 | 0.710 |
Why?
| | Coronary Sinus | 1 | 2020 | 7 | 0.700 |
Why?
| | Treatment Outcome | 14 | 2025 | 10219 | 0.690 |
Why?
| | Patient Discharge | 2 | 2025 | 836 | 0.690 |
Why?
| | Therapeutic Irrigation | 2 | 2019 | 76 | 0.680 |
Why?
| | Cardiac Catheterization | 2 | 2022 | 520 | 0.670 |
Why?
| | Shock | 1 | 2020 | 92 | 0.650 |
Why?
| | Length of Stay | 1 | 2025 | 1122 | 0.650 |
Why?
| | Coronary Artery Disease | 3 | 2014 | 679 | 0.630 |
Why?
| | Esophageal Fistula | 1 | 2019 | 18 | 0.620 |
Why?
| | Postoperative Complications | 5 | 2019 | 2477 | 0.610 |
Why?
| | Humans | 51 | 2025 | 129625 | 0.580 |
Why?
| | Heart Block | 1 | 2018 | 40 | 0.570 |
Why?
| | Electrocardiography | 6 | 2023 | 611 | 0.550 |
Why?
| | Cryosurgery | 1 | 2018 | 57 | 0.550 |
Why?
| | Tetralogy of Fallot | 1 | 2018 | 78 | 0.550 |
Why?
| | Practice Patterns, Physicians' | 2 | 2017 | 1271 | 0.530 |
Why?
| | Heart Valve Prosthesis | 1 | 2018 | 112 | 0.520 |
Why?
| | Tilidine | 1 | 2016 | 2 | 0.520 |
Why?
| | Pulmonary Valve | 1 | 2018 | 93 | 0.510 |
Why?
| | Coronary Artery Bypass | 1 | 2017 | 224 | 0.500 |
Why?
| | Oxycodone | 1 | 2016 | 43 | 0.490 |
Why?
| | Preoperative Care | 1 | 2018 | 338 | 0.490 |
Why?
| | Assisted Circulation | 1 | 2015 | 26 | 0.480 |
Why?
| | Antihypertensive Agents | 2 | 2019 | 485 | 0.480 |
Why?
| | Registries | 8 | 2025 | 1899 | 0.480 |
Why?
| | Naloxone | 1 | 2016 | 112 | 0.470 |
Why?
| | Aged | 23 | 2025 | 22061 | 0.470 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2017 | 248 | 0.460 |
Why?
| | Male | 30 | 2025 | 63670 | 0.450 |
Why?
| | Plaque, Atherosclerotic | 1 | 2014 | 55 | 0.440 |
Why?
| | Blue Cross Blue Shield Insurance Plans | 1 | 2013 | 1 | 0.420 |
Why?
| | Retrospective Studies | 17 | 2025 | 14522 | 0.420 |
Why?
| | United States Department of Veterans Affairs | 1 | 2017 | 623 | 0.420 |
Why?
| | Prescriptions | 2 | 2023 | 66 | 0.420 |
Why?
| | Cardiomyopathies | 3 | 2025 | 340 | 0.410 |
Why?
| | Middle Aged | 21 | 2025 | 31136 | 0.410 |
Why?
| | Hospitals, Teaching | 1 | 2013 | 114 | 0.410 |
Why?
| | Atrial Flutter | 2 | 2024 | 35 | 0.400 |
Why?
| | Thiophenes | 1 | 2013 | 117 | 0.390 |
Why?
| | Cardiac Surgical Procedures | 1 | 2018 | 506 | 0.390 |
Why?
| | Time Factors | 9 | 2025 | 6555 | 0.370 |
Why?
| | Tachycardia, Supraventricular | 2 | 2022 | 44 | 0.370 |
Why?
| | United States | 9 | 2025 | 13871 | 0.370 |
Why?
| | Heart Failure | 4 | 2021 | 2133 | 0.360 |
Why?
| | Healthcare Disparities | 1 | 2017 | 578 | 0.360 |
Why?
| | Administration, Oral | 2 | 2023 | 787 | 0.360 |
Why?
| | Female | 27 | 2025 | 68734 | 0.350 |
Why?
| | Piperazines | 1 | 2013 | 340 | 0.350 |
Why?
| | Patient Participation | 2 | 2024 | 414 | 0.350 |
Why?
| | Hypertension | 2 | 2019 | 1243 | 0.340 |
Why?
| | Atrioventricular Block | 2 | 2021 | 35 | 0.330 |
Why?
| | Acute Coronary Syndrome | 1 | 2013 | 267 | 0.320 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2013 | 443 | 0.320 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2512 | 0.310 |
Why?
| | Cost-Benefit Analysis | 2 | 2022 | 569 | 0.290 |
Why?
| | Bundle-Branch Block | 3 | 2023 | 30 | 0.280 |
Why?
| | Heart Conduction System | 2 | 2024 | 95 | 0.260 |
Why?
| | Cardiac Pacing, Artificial | 2 | 2023 | 86 | 0.260 |
Why?
| | Electric Countershock | 3 | 2023 | 105 | 0.240 |
Why?
| | Cardiovascular Diseases | 2 | 2024 | 2006 | 0.240 |
Why?
| | Heart Defects, Congenital | 2 | 2022 | 792 | 0.240 |
Why?
| | Clinical Decision-Making | 2 | 2024 | 301 | 0.230 |
Why?
| | Government Regulation | 1 | 2024 | 49 | 0.220 |
Why?
| | Off-Label Use | 1 | 2023 | 51 | 0.210 |
Why?
| | Death, Sudden, Cardiac | 2 | 2021 | 179 | 0.200 |
Why?
| | Risk Assessment | 5 | 2024 | 3262 | 0.200 |
Why?
| | Transposition of Great Vessels | 1 | 2022 | 36 | 0.200 |
Why?
| | Guideline Adherence | 2 | 2019 | 527 | 0.190 |
Why?
| | Sweden | 1 | 2022 | 93 | 0.190 |
Why?
| | Aged, 80 and over | 4 | 2019 | 7052 | 0.190 |
Why?
| | Prospective Studies | 5 | 2019 | 7135 | 0.190 |
Why?
| | Pulmonary Veins | 1 | 2022 | 98 | 0.180 |
Why?
| | Rivaroxaban | 1 | 2023 | 252 | 0.180 |
Why?
| | Accessory Atrioventricular Bundle | 1 | 2020 | 13 | 0.170 |
Why?
| | Ventricular Fibrillation | 1 | 2020 | 57 | 0.170 |
Why?
| | Bradycardia | 1 | 2021 | 53 | 0.170 |
Why?
| | Swine | 1 | 2023 | 764 | 0.170 |
Why?
| | Follow-Up Studies | 5 | 2024 | 4894 | 0.170 |
Why?
| | Cardiac Catheters | 1 | 2019 | 15 | 0.170 |
Why?
| | Death | 1 | 2020 | 117 | 0.170 |
Why?
| | Temperature | 1 | 2023 | 637 | 0.160 |
Why?
| | Papillary Muscles | 1 | 2019 | 14 | 0.160 |
Why?
| | Coffee | 1 | 2019 | 15 | 0.160 |
Why?
| | Tricuspid Valve Insufficiency | 1 | 2019 | 24 | 0.160 |
Why?
| | Electrodes | 1 | 2019 | 105 | 0.160 |
Why?
| | Technology | 1 | 2020 | 87 | 0.160 |
Why?
| | Aortic Valve Insufficiency | 1 | 2019 | 46 | 0.160 |
Why?
| | Inpatients | 1 | 2023 | 475 | 0.160 |
Why?
| | Ventricular Function, Left | 2 | 2020 | 528 | 0.160 |
Why?
| | Diffusion of Innovation | 1 | 2019 | 97 | 0.160 |
Why?
| | Mitral Valve Insufficiency | 1 | 2019 | 67 | 0.160 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2019 | 58 | 0.160 |
Why?
| | Action Potentials | 2 | 2019 | 485 | 0.150 |
Why?
| | Practice Guidelines as Topic | 2 | 2019 | 1501 | 0.150 |
Why?
| | Heart Valve Diseases | 1 | 2020 | 152 | 0.150 |
Why?
| | Heparin | 1 | 2020 | 254 | 0.150 |
Why?
| | Heart Rate | 2 | 2019 | 802 | 0.150 |
Why?
| | Prosthesis Implantation | 1 | 2019 | 146 | 0.150 |
Why?
| | Coronary Angiography | 2 | 2017 | 306 | 0.150 |
Why?
| | Myocardial Infarction | 2 | 2016 | 1021 | 0.150 |
Why?
| | Equipment Design | 1 | 2019 | 514 | 0.140 |
Why?
| | Echocardiography, Stress | 1 | 2017 | 20 | 0.140 |
Why?
| | Adult | 7 | 2023 | 35599 | 0.140 |
Why?
| | Decision Support Techniques | 1 | 2021 | 398 | 0.140 |
Why?
| | Sarcoidosis | 1 | 2019 | 156 | 0.140 |
Why?
| | Ventricular Function, Right | 1 | 2019 | 276 | 0.130 |
Why?
| | Anti-Arrhythmia Agents | 3 | 2023 | 112 | 0.130 |
Why?
| | Hot Temperature | 1 | 2019 | 370 | 0.130 |
Why?
| | Pharmacovigilance | 1 | 2016 | 21 | 0.130 |
Why?
| | Diagnosis, Differential | 1 | 2020 | 1432 | 0.130 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 1947 | 0.120 |
Why?
| | Intra-Aortic Balloon Pumping | 1 | 2015 | 17 | 0.120 |
Why?
| | World Health Organization | 1 | 2016 | 110 | 0.120 |
Why?
| | Vasodilator Agents | 1 | 2017 | 326 | 0.120 |
Why?
| | Disease Management | 1 | 2019 | 588 | 0.120 |
Why?
| | Shock, Cardiogenic | 1 | 2015 | 60 | 0.120 |
Why?
| | Drug Combinations | 1 | 2016 | 331 | 0.120 |
Why?
| | Stroke Volume | 3 | 2025 | 592 | 0.110 |
Why?
| | Arterial Occlusive Diseases | 1 | 2014 | 80 | 0.110 |
Why?
| | Chagas Cardiomyopathy | 1 | 2014 | 22 | 0.110 |
Why?
| | Prasugrel Hydrochloride | 1 | 2013 | 22 | 0.100 |
Why?
| | Insurance, Pharmaceutical Services | 1 | 2013 | 23 | 0.100 |
Why?
| | Contraindications | 1 | 2013 | 90 | 0.100 |
Why?
| | Heart Ventricles | 1 | 2018 | 781 | 0.100 |
Why?
| | Michigan | 1 | 2013 | 104 | 0.100 |
Why?
| | Program Evaluation | 1 | 2017 | 875 | 0.100 |
Why?
| | Drug Utilization Review | 1 | 2013 | 57 | 0.100 |
Why?
| | Diabetic Angiopathies | 1 | 2015 | 261 | 0.100 |
Why?
| | Blood Pressure | 1 | 2019 | 1736 | 0.100 |
Why?
| | Drug Utilization | 1 | 2013 | 171 | 0.100 |
Why?
| | Recurrence | 1 | 2015 | 1011 | 0.090 |
Why?
| | Hemorrhage | 1 | 2016 | 680 | 0.090 |
Why?
| | Societies, Medical | 1 | 2015 | 744 | 0.090 |
Why?
| | Catheters | 2 | 2022 | 66 | 0.090 |
Why?
| | Seizures | 1 | 2014 | 401 | 0.090 |
Why?
| | Comorbidity | 1 | 2015 | 1547 | 0.090 |
Why?
| | Quality Indicators, Health Care | 1 | 2013 | 298 | 0.090 |
Why?
| | Medication Adherence | 1 | 2015 | 558 | 0.080 |
Why?
| | Incidence | 3 | 2021 | 2641 | 0.080 |
Why?
| | Echocardiography | 2 | 2025 | 634 | 0.080 |
Why?
| | Hospital Mortality | 1 | 2013 | 848 | 0.080 |
Why?
| | Longitudinal Studies | 1 | 2015 | 2720 | 0.070 |
Why?
| | Young Adult | 2 | 2020 | 12455 | 0.060 |
Why?
| | Quality Improvement | 1 | 2013 | 1101 | 0.060 |
Why?
| | Bundle of His | 1 | 2023 | 17 | 0.050 |
Why?
| | Atrioventricular Node | 1 | 2021 | 15 | 0.050 |
Why?
| | Cardiac Electrophysiology | 1 | 2021 | 18 | 0.050 |
Why?
| | Tachycardia | 1 | 2021 | 57 | 0.050 |
Why?
| | Cross-Sectional Studies | 2 | 2025 | 5075 | 0.050 |
Why?
| | Animals | 1 | 2023 | 35391 | 0.040 |
Why?
| | Colorado | 2 | 2021 | 4404 | 0.040 |
Why?
| | Patient Readmission | 2 | 2016 | 653 | 0.040 |
Why?
| | Artificial Intelligence | 1 | 2023 | 245 | 0.040 |
Why?
| | Antithrombins | 1 | 2020 | 58 | 0.040 |
Why?
| | Tricuspid Valve | 1 | 2019 | 27 | 0.040 |
Why?
| | Physician-Patient Relations | 1 | 2024 | 540 | 0.040 |
Why?
| | Mitral Valve | 1 | 2019 | 85 | 0.040 |
Why?
| | Systole | 1 | 2019 | 191 | 0.040 |
Why?
| | Prognosis | 2 | 2019 | 3774 | 0.040 |
Why?
| | Interviews as Topic | 1 | 2021 | 704 | 0.040 |
Why?
| | Hospitalization | 2 | 2021 | 2057 | 0.040 |
Why?
| | Myocardial Ischemia | 1 | 2019 | 259 | 0.040 |
Why?
| | Drug Therapy, Combination | 1 | 2019 | 1042 | 0.030 |
Why?
| | Pilot Projects | 1 | 2021 | 1592 | 0.030 |
Why?
| | Reoperation | 1 | 2018 | 541 | 0.030 |
Why?
| | Medicare | 1 | 2021 | 708 | 0.030 |
Why?
| | Research Design | 1 | 2021 | 1045 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 1872 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2016 | 1198 | 0.030 |
Why?
| | Prevalence | 1 | 2019 | 2564 | 0.030 |
Why?
| | Child | 2 | 2022 | 20884 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2627 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3080 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2021 | 5415 | 0.020 |
Why?
| | Cohort Studies | 1 | 2014 | 5426 | 0.010 |
Why?
| | Adolescent | 1 | 2022 | 20412 | 0.010 |
Why?
|
|
Sandhu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|